Spotlight
Topic
Brand Insights
Subscribe
- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
PEE readership survey v2
PEE readership survey v. 2
Q1
How long have you been a reader of Pharmaceutical Executive Europe?
Since its launch in 2003
2 years
1 year
Less than a year
Q2
Overall, how long do you spend reading an issue of Pharmaceutical Executive Europe?
3 years
6 months
2 years
1 month
1 year
1 week
Q3
How long do you keep your issues of Pharmaceutical Executive Europe?
3 years
6 months
2 years
1 month
1 year
1 week
Q4
Apart from you how many other people read your copy of Pharmaceutical Executive Europe?
5+
2
4
1
3
None
Q5
How often do you read the following sections of Pharmaceutical Executive Europe?
Executive Profile
From the Editor
News & analysis
Brussels report
The Mix
On the Move
Calendar of events
Last Word
Q6
How interested are you in the following sections of Pharmaceutical Executive Europe? (5 = very interested, 1 = not interested)
Executive Profile
From the Editor
News & analysis
Brussels Report
The Mix
On the Move
Calendar of events
Last Word
Q7
How would you rate the following sections of Pharmaceutical Executive Europe?
Executive Profile
From the Editor
News & analysis
Brussels Report
The Mix
On the Move
Calendar of events
Last Word
Q8
How would you rate Pharmaceutical Executive Europe on each of the following criteria?
Range of topics covered
Front cover design
Page layout and design
Relevance to your job
As a strategic business management and marketing publication for the pharma industry
Q9
How much coverage of the following topics would you like to see in future issues?
Strategic outsourcing
Market research and analysis
Sales and marketing strategies
Managed care
Therapeutic disease management
Contract manufacturing
Clinical trials
Drug discovery technologies
Drug delivery
Executive profiles
Supply chain
RFID and packaging
European industry news
Q10
Are there any other subjects/topics that you would like to see more coverage of in Pharmaceutical Executive Europe?
Q11
Is there anything you would change about Pharmaceutical Executive Europe?
Q12
How many off site meetings do you plan a year?
Q13
Which of the following are you involved in planning?
Sales and training meetings
Meeting planning/site selection
Convention planning
Trade show and exhibition planning
Board meetings
Incentive travel programmes
Other, please specify
Q14
In which of the following locations do you plan to hold meetings?
UK
Switzerland
Germany
Denmark
France
Sweden
Italy
Finland
Spain
Norway
Netherlands
Central and Eastern Europe
Ireland
Q15
Which of the following clinical trials related products and services are you involve in purchasing
Patient recruitment
Site selection
Data capture
None of the above
Q16
Which of the following products/services related to consulting services are you involved in purchasing?
Business development
Supply chains
Regulatory
M&A
Licensing
Security
Legal
Site/facility expansion
HR/management
None of the above
E-business
Q17
Which of the following products/services related to outsourcing services are you involved in purchasing?
Clinical research
Sales
Manufacturing
Drug Discovery
Information technology
None of the above
Q18
Does your work scope cover the European region?
Yes
No
Q19
Does your work scope cover the Asia Pacific region?
Yes
No
Q20
We are launching a new digital magazine, Pharmaceutical Executive Asia Pacific. Would you like to submit an article for inclusion in this new magazine? (please note, by ticking yes you will be contacted by an editor for further information)
Yes
No
Q21
What is your job function?
Corporate management
IT
Marketing management
Financial management
Strategic planning
Training and development
R&D/QA/QC management
Regulatory
Clinical management
Sales management
Q22
Do you recommend, specify or authorise the purchase of services, equipment or supplies?
I authorise
I specify
I recommend
No involvement
Q23
Name
Q24
Company
Q25
Email address
Q26
Telephone No.
Recent Videos
Related Content
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024Podcast
In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024Podcast
In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
